CancerGene Connect Taps Seasoned Executive John Oberg as Vice President of Sales and Marketing

Dallas, TX, January 31, 2017 --(PR.com)-- CancerGene Connect, a wholly owned Subsidiary of OMMDOM, Inc., a software development, commercialization, and technology sales company whose core competency is healthcare software, has announced the appointment of John Oberg as their inaugural Vice President of Sales and Marketing. Oberg will assume his new role effective on Monday, February 6th.

In this role, Oberg will be responsible for all direct sales, reseller functions and marketing initiatives at OMMDOM including CancerGene Connect, the most complete and modern family history cloud-based platform on the market. Oberg brings executive sales, business development and marketing leadership experience at both large enterprise organizations and startups, one of which was acquired by a public company and had a successful IPO. Most recently, he held the position of Director of National Sales at Valassis, a recognized worldwide leader in intelligent media delivery.

“Family history is rapidly gaining in focus and attention as an opportunity to directly affect disease prevention. Although most frequently discussed in relation to cancer, it also has significant and growing applications in heart, metabolic, neurological, and other diseases,” said Richard Burghardt, CEO of OMMDOM and CancerGene Connect. “We are pleased to have John oversee our direct sales and marketing efforts. His proven ability to execute against business objectives to drive significant revenue will make him an asset to the leadership team as we look to spearhead new growth opportunities outside of inherited cancer.”

“I am proud to play a role in the development and execution of the company’s growth strategy,” said Mr. Oberg. “The CancerGene Connect platform is incredibly flexible and customizable. In addition to inherited cancer, our goal is to capitalize on new application delivery opportunities, such as cardiovascular, prenatal, general adult inherited disease, and high volume colorectal cancer risk screening. We also want to broaden our scope of strategic partnerships with genetic testing laboratories and remote counseling service providers.”

For more information, please contact us at (972) 755-9387 or info@cagene.com or visit the CancerGene Connect website at www.cagene.com.

About OMMDOM and CancerGene Connect: OMMDOM is a software development, commercialization, and technology sales company whose core competency is healthcare software - most specifically family history collection and utilization software solutions. CancerGene Connect was originally developed by UT Southwestern, who runs the largest hereditary cancer genetic counseling practice in the country, and is the most complete and modern family history cloud-based genetic counseling productivity platform on the market. CancerGene Connect not only greatly streamlines the complex and tedious process of gathering complete patient health and family histories, it utilizes all of this data to draw pedigrees, family tree charts, run risk algorithms, generate reports, and populate a risk assessment database for research.